Alliance Pharma (LON:APH) Reaches New 1-Year High – Here’s What Happened

Alliance Pharma plc (LON:APH)’s share price hit a new 52-week high on Thursday . The company traded as high as GBX 61.60 ($0.77) and last traded at GBX 61.40 ($0.77), with a volume of 519622 shares changing hands. The stock had previously closed at GBX 61.20 ($0.77).

Wall Street Analyst Weigh In

Separately, Berenberg Bank downgraded shares of Alliance Pharma to a “hold” rating and cut their target price for the stock from GBX 7,000 ($87.51) to GBX 6,250 ($78.13) in a research report on Wednesday, January 29th.

Alliance Pharma Stock Performance

The company has a market cap of £331.91 million, a P/E ratio of -1,023.33, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46. The business has a fifty day simple moving average of GBX 51.89 and a two-hundred day simple moving average of GBX 45.13.

About Alliance Pharma

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.